Free Newsletter
Top-ranked woman to retire from J&J
There's another big executive departure coming in the world of Big Pharma: this time it's Christine Poon (photo), vice chairman of Johnson & Johnson and worldwide chair of its pharmaceuticals division. Poon, 56, plans to retire on March 1, J&J announced today, saying that it will announce a succession plan "in a timely fashion."
With 20 years in pharma, 15 of them at Bristol-Myers Squibb before she joined J&J, Poon has been a heavyweight in the industry. She's the top-ranked woman in the drug business, and, according to Forbes, one of the most respected. The magazine ranked her as the 26th most powerful woman in business in 2006.
- see J&J's release
- read the Forbes article
- get more from Pharmalot
Related Article:
J&J reorg anoints growth czar
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: